— Know what they know.
Not Investment Advice
Also trades as: 4503.T (JPX) · $vol 92M · ALPMY (OTC) · $vol 2M

ALPMF OTC

Astellas Pharma Inc.
1W: -4.1% 1M: -3.0% 3M: -1.6% YTD: +9.1% 1Y: +29.5% 3Y: +12.3% 5Y: -2.9%
$14.37
-0.30 (-2.06%)
 
Weekly Expected Move ±11.1%
$11 $13 $14 $16 $18
OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 47 · $25.7B mcap · 1.72B float · 0.0002% daily turnover · Short 45% of daily vol

📊 Key Metrics

TTM
$2,151B
Revenue
+12.5% YoY
$293B
Net Income
+477.5% YoY
$512B
Free Cash Flow
+225.0% YoY
75.9%
Gross Margin
14.5%
Op. Margin
8.1%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE17.5%
ROA8.5%
ROIC14.8%

Valuation

P/E11.0
P/B2.1
EV/EBITDA0.0

Leverage

Debt/Equity0.31
Current Ratio1.17
Interest Cov.34.3x

Quality Scores

Piotroski F8/9
Altman Z—
Beneish M-2.53

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms